CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention Revascularization of left main coronary artery Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes MINOCA: a heterogenous group of conditions associated with myocardial damage Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective

Original Research2021 Jan 5;1-10.

JOURNAL:J Natl Compr Canc Netw. Article Link

Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study

AA Matthews, SP Hinton, S Stanway et al. Keywords: breast cancer; CVD; screening and monitoring

Full Text PDF